Karolina Dorobisz, 1 Tadeusz Dorobisz, 2 Dariusz Janczak, 2 and Tomasz Zatoński 1 Author information Article notes Copyright and License information PMC Disclaimer Ther Clin Risk Manag. 2021; 17: 1023–1026. Published online 2021 Sep 21. doi: 10.2147/TCRM.S314923 PMCID: PMC8464303PMID: 34584416 Abstract Acute respiratory syndrome, associated with […]
Potential New Treatment for “Brain Fog” in Long COVID Patients
December 12, 2022 by Isabella Backman Individuals with long COVID, sometimes referred to as “long-haulers,” experience symptoms that may persist for weeks, months, or even years after their acute viral […]
Ritalin (Methylphenidate) For Chronic Fatigue Syndrome and Fibromyalgia
Methylphenidate (Ritalin, Concerta) Ritalin Is… a central nervous system stimulant. Created in 1954, Ritalin has been in use for over sixty years. (Check out a History of Ritalin here). It was […]
New research helps explain how Ritalin sharpens attention
Date: April 29, 2022 Source: University of Pittsburgh Science Daily Summary: Researchers found animals that had taken methylphenidate performed better on a visual task of attention, and that the improvement […]
Exercise is the Most Important Medicine for COVID-19
Torres, Georgia PhD; Constantinou, Demitri MBChB, FACSM; Gradidge, Philippe PhD; Patel, Deepak MD; Patricios, Jon MBBCh, MMedSci Current Sports Medicine Reports 22(8):p 284-289, August 2023. | DOI: 10.1249/JSR.0000000000001092 Abstract COVID-19 infection and long COVID […]
Risk of smell loss from covid has plummeted since 2020
New research shows steep drops in the rates of smell loss with recent omicron variants By Aara’L Yarber August 2023 When the pandemic began, losing your sense of smell was considered […]
Can This Common Medication Help Reduce The Risk Of Long COVID?
A recent study suggests that the treatment may help some high-risk people following an infection. By Casey Clark Aug 29, 2023 It seems like every time you turn on the news […]
SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy
Marcelo Merello, Kailash P Bhatia, Jose A Obeso Published: November 27, 2020 DOI: https://doi.org/10.1016/S1474-4422(20)30442-7 Lancet Neurology VOLUME 20, ISSUE 2, P94-95, FEBRUARY 2021 During the pandemic it has become clear that severe […]
Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China
Front. Aging Neurosci., 05 May 2023 Sec. Parkinson’s Disease and Aging-related Movement DisordersVolume 15 – 2023 | https://doi.org/10.3389/fnagi.2023.1138418 Li Wu1† Jun Shen1† Yuhan Jiang1 Xiaolei Shen1 Ping Wang1 Xin Nie2 Wenyan Kang3,4* Jianren Liu1* Wei Chen1* Background: Clinical manifestations of […]
Early-stage trial for Parkinson’s disease therapy shows signs of promise
Small trial of Bemdaneprocel, which aims to replace dopamine-producing neurons, raises hope for treatment. Hannah Devlin Science correspondent 28 Aug 2023 03.00 EDT Scientists have reported early success in a trial […]